1 April 2020 Blog Post: Good News and Bad News
In one of the latest developments in coronavirus disease (COVID-19) comes some good news from a randomized clinical trial in China. Among 62 patients hospitalized with COVID-19, there was evidence that hydroxychloroquine helped shorten the time to recovery.
At Santa Monica Primary Care, we are now able to refer interested patients to an ongoing clinical trial of hydroxychloroquine. The trial is recruiting test proven, symptomatic COVID-19 cases within 4 days of symptom onset as well as any household contacts exposed to a known COVID-19 case.
Additionally, there are several independent efforts that will seek to enroll COVID-19 patients in order to perform contact tracing effort via cell phone data. While these are not yet up and running, it will provide yet another opportunity for interested patients to participate.
𝗦𝗶𝗴𝗻 𝗨𝗽 𝗳𝗼𝗿 𝗢𝘂𝗿 𝗡𝗲𝘄𝘀𝗹𝗲𝘁𝘁𝗲𝗿
by submitting this form you indicate you have
of Use. Please contact us to for us for more